Form 4: Rallybio Corp Director Kush Parmar Acquires Options

Director Kush Parmar acquired options to purchase 16,500 shares of Rallybio Corp common stock at an exercise price of $1.91 on May 15, 2024.

Summary

• Kush Parmar, a director of Rallybio Corp, filed a Form 4 on May 17, 2024, reporting a transaction.
• On May 15, 2024, Parmar acquired options to purchase 16,500 shares of Rallybio Corp common stock.
• The exercise price of the options is $1.91.
• The options were granted under the company's 2021 Equity Incentive Plan and vest on the earlier of May 15, 2025, or the date of the company's 2025 Annual Meeting of Stockholders.
• The options expire on May 15, 2034.
• Following the transaction, Parmar directly owns 16,500 derivative securities.

Sentiment

Score: 5

Explanation: The document is a neutral regulatory filing detailing an insider transaction. It doesn't inherently convey positive or negative sentiment.

Industry Context

This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. It provides transparency into the actions of company insiders.

Stakeholder Impact

• The transaction could have a minor positive impact on shareholder sentiment as it shows a director increasing their stake in the company.

Key Dates